drugset / Trial / NCT00724932

Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)

NCT00724932

Phase 3 Completed 140 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The current trial was designed to demonstrate faster recovery from a neuromuscular blockade (NMB) induced by rocuronium after reversal at 1-2 Post Tetanic Count (PTC) by 4.0 mg.kg-1 sugammadex compared to 50 µg.kg-1 neostigmine at reappearance of second twitch (T2) in participants undergoing laparoscopic cholecystectomy or appendectomy under propofol anesthesia, to compare safety and to evaluate operating room and Post Anesthetic Care Unit (PACU) length of stay.

Timeline

Start
2008-07-16
Primary completion
2009-04-01
Completion
2009-05-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 50 ug/kg
Subject Sugammadex Other / unclassified 4 mg/kg
Background Atropine Other / unclassified 10 ug/kg
Background Rocuronium Other / unclassified 0.1 mg/kg Intravenous
Background Rocuronium Other / unclassified 0.2 mg/kg Intravenous

Indications

No indication recorded.